The MedTech Actuator Accelerator is Asia Pacific’s industry-led, venture-backed, 12-month acceleration program, which simultaneously accelerates technology development, builds team capability, and provides a chance to access up to $3m+ seed-series A investment.
ELIGIBILITY:
- Founders based in Australia, Singapore or internationally with an ability to travel to attend certain intensive sprints and a Demo Day (February 2023) in person
- Teams are required to incorporate as a company to enter the MedTech Actuator Program, however the group does not need to be incorporated at the time of Application. MTAC will provide the initial assistance in setting up the company
- In the unfunded track, you are expected to have at least $50k cash flow to cover the expenses associated with reaching certain milestones (regulatory strategy, reimbursement strategy, IP, etc)
- MTAC takes 5% non-negotiable program fee
PROGRAM DETAILS:
MedTech Actuator – Phase One, July – October 2022
Phase 1 of the MedTech Actuator comprises 4 months of intensive sprints, whereby founders participate in structured workshop sessions and hands-on learning activities for three to five days at the beginning of each month. Each sprint is focused on critical elements associated with commercialisation.
MedTech Actuator – Phase Two, November 2022 – April, 2023
Self-structured, intensive growth – meeting with mentors and industry experts to refine strategy and prepare for investment.
Medtech Actuator – Phase Three, May – June 2023
Internationalisation and global growth of business workshops and an international trade mission.
This program is powered by MTPConnect’s $32 million Researcher Exchange and Development within Industry (REDI) initiative made possible by the Medical Research Future Fund (MRFF).
Apply by March 6.
